Lipoxygenase Gene Disruption Studies

Status and Applications
  • Eric N. Johnson
  • Duxin Sun
  • Xin-Sheng Chen
  • Colin D. Funk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 447)

Abstract

Mammalian lipoxygenase enzymes (Figure 1) are derived from a multi-gene family, each member consisting of 14 exons (1,2). The 5-lipoxygenase gene is distinct from other lipoxygenase genes in its large size and its location on a separate chromosome (10q1 1.2 in humans and central chromosome 6 in mice) (1-5). A cluster of lipoxygenase genes located on mouse chromosome 11 (5,6) contains genes that encode three distinct 12(S)-lipoxy-genases, referred to as “platelet-type,” “leukocyte-type” and “epidermal-type” (1,7,8). Although substantial information is known about the ability of the various lipoxygenases to oxygenate arachidonic acid at a specific carbon atom position, relatively little is understood regarding the physiological roles of the various metabolites such as 12-hy-dro(pero)xy-eicosatetraenoic acid (12-H(p)ETE) and 15-H(p)ETE. Diverse biological activities have been assigned to lipoxygenase-derived eicosanoids and pathophysiological elevations in their synthesis have been reported (9-11). However, it remains to be determined how relevant these findings are to physiological models in vivo. Thus, we undertook the approach of targeted lipoxygenase gene disruption to elucidate possible functions associated with the various eicosanoid metabolites generated from these pathways. In this review, an effort will be made to emphasize the current status of experimental results using 5-lipoxygenase and 12-lipoxygenase-deficient mice and potential future applications in disease models and other physiological studies.

Keywords

Aspirin Psoriasis Gravel Histidine Thrombin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Funk, C.D. (1996) Biochim. Biophys. Acta 1304, 65–84.PubMedGoogle Scholar
  2. 2.
    Funk, C.D. (1993) Prog. Nucl. Acid Res. and Mol. Biol. 45, 67–98.CrossRefGoogle Scholar
  3. 3.
    Funk, C.D., Hoshiko, S., Matsumoto, T., Rark, O. and Samuelsson, B. (1989) Proc. Natl. Acad. Sci. USA 86, 2587–2591.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen, X.-S., Naumann, T.A., Kurre, U., Jenkins, N.A., Copeland, N.G. and Funk, C.D. (1995) J. Biol. Chem. 270, 17993–17999.PubMedCrossRefGoogle Scholar
  5. 5.
    Funk, C.D., Funk, L.B., FitzGerald, G.A. and Samuelsson, B. (1992) Proc. Natl. Acad. Sci. USA 89, 3962–3966.PubMedCrossRefGoogle Scholar
  6. 6.
    Chen, X.-S., Kurre, U., Jenkins, N.A., Copeland, N.G. and Funk, C.D. (1994) J. Biol. Chem. 269, 13979–13987.PubMedGoogle Scholar
  7. 7.
    Funk, C.D., Keeney, D.S., Oliw, E.H., Boeglin, W.E. and Brash, A.R. (1996) J. Biol. Chem. 271, 23338–23344.PubMedCrossRefGoogle Scholar
  8. 8.
    Yoshimoto, T. and Yamamoto, S. (1995) J. Lipid Mediators 12, 195–212.CrossRefGoogle Scholar
  9. 9.
    Yamamoto, S. (1993) Biochim. Biophys. Acta 1128, 117–131.Google Scholar
  10. 10.
    Samuelsson, B., Dahlén, S.-E., Lindgren, J.-Å, Rouzer, C.A. and Serhan, C.N. (1987) Science 237, 1171–1175.PubMedCrossRefGoogle Scholar
  11. 11.
    Spector, A.A., Gordon, J.A. and Moore, S.A. (1988) Prog. Lipid Res. 27, 271–323.PubMedCrossRefGoogle Scholar
  12. 12.
    Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Nadeau, J.H., Eppig, J.T., Maltais, L.J., Miller, J.C, Dietrich, W.F., Steen, R.G., Lincoln, S.E., et al. (1993) Science 262, 67–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen, X.-S., Sheller, J.R., Johnson, E.N. and Funk, C.D. (1994) Nature 372, 179–182.PubMedCrossRefGoogle Scholar
  14. 14.
    Goulet, J.L., Snouwaert, J.N., Latour, A.M., Coffman, T.M. and Koller, B.H. (1994) Proc. Natl. Acad. Sci. USA 91 12852–12856.PubMedCrossRefGoogle Scholar
  15. 15.
    Henderson, W.R. (1994) Ann. Intern. Med. 121, 684–697.PubMedGoogle Scholar
  16. 16.
    Lewis, R.A., Austen, K.F. and Soberman, R.J. (1990) N. Engl. J. Med. 323, 645–655.PubMedCrossRefGoogle Scholar
  17. 17.
    Hay, D.W.P., Torphy, T.J. and Undem, B.J. (1995) Trends Pharm. Sci. 16, 304–309.PubMedCrossRefGoogle Scholar
  18. 18.
    Smith, L.J. (1996) Arch. Intern. Med. 156, 2181–2189.PubMedCrossRefGoogle Scholar
  19. 19.
    Po, Y.-T., Larsen, G.L. and Irvin, C.G. (1995) Eur. Resp. Rev. 5, 224–230.Google Scholar
  20. 20.
    Irvin, C.G., Tu, Y.-R., Sheller, J.R., Funk, C.D. (1997) Am. J. Physiol. 272, L1058–L1063.Google Scholar
  21. 21.
    Funk C.D, Chen, X.S, Sheller, J.R., Tu, Y-P., Irvin, C.G. (1997) In: Lung Biology in Health and Disease, “Eicosanoids, Aspirin and Asthma, ” ed. A. Szczeklik, in press.Google Scholar
  22. 22.
    Yamaoka, K.A., Claesson, H.-E, and Rosen, A. (1989) J. Immunol. 143, 1996–2000.PubMedGoogle Scholar
  23. 23.
    Yamaoka, K.A., Dugas, B., Paul-Eugene, N., Mencia-Huerta, J.M., Braquet, P., and Kolb, J.P. (1994) Cell Immunol. 156, 124–134.PubMedCrossRefGoogle Scholar
  24. 24.
    Shukla, S.D. (1992) FASEB J. 6, 2296–2301.PubMedGoogle Scholar
  25. 25.
    Voelkl, N.F., Worthen, S., Reeves, J.T., Hanson, P.M and Murphy, R.C (1982) Science 218, 286–288.CrossRefGoogle Scholar
  26. 26.
    Stahl, G.L. and Lefer, A.M. (1987) Circul. Shock 23, 165–177.Google Scholar
  27. 27.
    Chen, X.-S. and Funk, C.D., unpublished observations.Google Scholar
  28. 28.
    Piper, P.J. and Stewart, A.G. (1986) Br. J. Pharmacol. 88, 595–605.PubMedGoogle Scholar
  29. 29.
    Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E., and Smith, M.J. (1980) Nature 286, 264–265.PubMedCrossRefGoogle Scholar
  30. 30.
    Powell, W.S., Chung, D., and Gravel, S. (1995) J. Immunol. 154, 4123–4132.PubMedGoogle Scholar
  31. 31.
    Byrum, R.S., Goulet, J.L., Griffiths, R.J. and Koller, B.H. (1997) J. Exp. Med. 185, 1065–1075.PubMedCrossRefGoogle Scholar
  32. 32.
    Secor, W.E., Powell, M.R., Morgan, J., Wynn, T.A. and Funk, CD. (1997) manuscript submitted.Google Scholar
  33. 33.
    Bailie, M.B., Standiford, T.J., Laichalk, L.L., Coffey, M.J., Strieter, R. and Peters-Golden, M. (1996) J. Immunol. 157, 5221–5224.PubMedGoogle Scholar
  34. 34.
    Sun, D. and Funk, CD. (1996) J. Biol Chem. 271, 24055–24062.PubMedCrossRefGoogle Scholar
  35. 35.
    Rapoport, S., and Schewe, T. (1986) Biochim. Biophys. Acta 864, 471–495.PubMedGoogle Scholar
  36. 36.
    Nishiyama, M., Watanabe, T., Ueda, N., Tsukamoto, H. and Watanabe, K. (1993) J. Histochem. Cytochem. 41, 111–117.PubMedCrossRefGoogle Scholar
  37. 37.
    Hada, T., Hagiya, H., Suzuki, H., Arakawa, T., Nakamura, M., Matsuda, S., Yoshimoto, T., Yamamoto, S., Azekawa, T., Morita, Y, Ishimura, K. and Kim, H.-Y. (1994) Biochim. Biophys. Acta 1211, 221–228.PubMedGoogle Scholar
  38. 38.
    Piomelli, D. and Greengard, P. (1990) Trends Pharmacol. Sci. 11, 367–373.PubMedCrossRefGoogle Scholar
  39. 39.
    Hamberg, M. and Samuelsson, B. (1974) Proc. Natl Acad. Sci. USA 71, 3400–3404.PubMedCrossRefGoogle Scholar
  40. 40.
    Takahashi, Y, Reddy, G.R., Ueda, N., Yamamoto, S., and Arase, S. (1993) J. Biol Chem. 268, 16443–16448.PubMedGoogle Scholar
  41. 41.
    Hussain, H., Shornick, L.P., Shannon, V.R., Wilson, J.D., Funk, C.D., Pentland, A.P., and Holtzman, M.J. (1994) Am. J. Physiol. 266, C243–C253.PubMedGoogle Scholar
  42. 42.
    Johnson, E.N., Brass, L.F. and Funk, C.D., (1998) Proc. Natl. Acad. Sci. USA 95, 3100–3105.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers, New York 1999

Authors and Affiliations

  • Eric N. Johnson
    • 1
    • 2
  • Duxin Sun
    • 1
    • 2
  • Xin-Sheng Chen
    • 1
    • 2
  • Colin D. Funk
    • 1
    • 2
  1. 1.Center for Experimental TherapeuticsUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of PharmacologyVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations